Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
5
Number of overlapping holdings
12.2%
% of GDOC's 43 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GDOC |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 10.4% | 17.0% | 10.4% | |
ABBVIE INC | 4.7% | 7.9% | 4.7% | |
AMGEN INC | 4.6% | 5.9% | 4.6% | |
BIOGEN IDEC INC | 2.8% | 3.4% | 2.8% | |
ALNYLAM PHARMACEUTICALS INC | 1.0% | 4.0% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to MEDX
ASTRAZENECA PLC | 6.2% | |
BOSTON SCIENTIFIC CORP | 5.9% | |
NOVO NORDISK A/S-B | 5.8% | |
INTUITIVE SURGICAL INC | 5.0% | |
DANAHER CORP | 3.8% | |
METTLER-TOLEDO INTERNATIONAL | 3.4% | |
NEUROCRINE BIOSCIENCES INC | 3.4% | |
INSULET CORP | 3.4% | |
HUMANA INC | 3.4% | |
COOPER COS INC/THE | 3.3% |
GDOC Underweight Relative to MEDX
ELI LILLY & CO | -6.6% | |
NOVARTIS AG-ADR | -6.1% | |
ASTRAZENECA PLC-SPONS ADR | -5.8% | |
BRISTOL-MYERS SQUIBB CO | -4.7% | |
REGENERON PHARMACEUTICALS | -4.5% | |
JOHNSON & JOHNSON | -4.5% | |
MERCK & CO. INC. | -4.2% | |
PFIZER INC | -4.0% | |
ALKERMES PLC | -3.4% | |
ABBVIE INC | -3.3% |